Implications of Indian IP policy on patenting activity of pharmaceutical multinational corporations in India
P. Venkataraman, Gauri Bhagwat, Vasanti Deshpande and Kavita Lanke
Year of publication: |
2015
|
---|---|
Authors: | Venkataraman, P. ; Bhagwat, Gauri ; Deshpande, Vasanti ; Lanke, Kavita |
Published in: |
International journal of intellectual property management : IJIPM. - Genève [u.a.] : Inderscience Enterprises, ISSN 1478-9647, ZDB-ID 2451202-3. - Vol. 8.2015, 3/4, p. 249-266
|
Subject: | TRIPS | pharmaceutical multinational corporations | cancer | tumours | AIDS | HIV | tuberculosis | malaria | arthritis | osteoporosis | compulsory license | intellectual property rights | Indien | India | Multinationales Unternehmen | Transnational corporation | Immaterialgüterrechte | Intellectual property rights | Patent | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Patentrecht | Patent law | Lizenz | Licence | Wirkungsanalyse | Impact assessment | Krebskrankheit | Cancer | Gesundheitsvorsorge | Preventive care | Welt | World | Gesundheitspolitik | Health policy |
Saved in:
Saved in favorites
Similar items by subject
-
Sarnoff, Joshua D., (2020)
-
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
Correa, Carlos María, (2020)
-
Compulsory licensing : implications on multinational drug companies
Prasad, Vure, (2013)
- More ...
Similar items by person